Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appt and Bank Funding

14 Feb 2007 07:01

Torex Retail PLC14 February 2007 Torex Retail plc (the "Company") Appointment of New Chairman and Increased Bank Funding Torex Retail plc, a leading global retail systems provider, today provides afurther update as to its board composition and financing arrangements. The Company announces that Steve Marshall has been appointed to the main Boardwith immediate effect as Non-executive Chairman. Mr Marshall has had aprestigious career in industry, including as CEO of both Railtrack PLC and ThornPLC, having also been group finance director at both companies. He is currentlynon-executive chairman of Delta PLC and a non-executive director of BalfourBeatty PLC and Southern Water Services Ltd. He was also executive chairman ofQueens Moat Houses PLC. This appointment follows those recently of Keith Taylor as Acting ChiefExecutive Officer and Iain Lynam as Chief Restructuring Officer, all of whichconsiderably strengthen the Board's operational and corporate restructuringexperience. The Company also announces that its syndicate of banks has agreed to provide therequested additional short-term working capital facility of £15.0 million. TheBoard considers that this will be sufficient to meet the Company's short-termworking capital requirements. The £15.0 million is in addition to the Company'sexisting total banking facilities of £152.5 million comprising term loans andoverdraft facilities. The Company expects to enter into further discussions with its bankers withrespect to its medium to long term financing requirements in the next fewmonths, when the Company has finalised results for the financial year ended 31December 2006 and has an up to date view of the 2007/2008 trading prospects. The Board is very pleased that it has concluded discussions with the Company'slenders with respect to its short-term financing requirements and that theCompany's lenders remain supportive. The Board is also delighted to haveappointed somebody of the calibre of Steve Marshall, whose experience andguidance will be of great benefit to the Company during this period. - Ends - Enquiries: Keith Taylor Acting CEO, Torex Retail plc Tel: 0870 300 6061 Ginny Pulbrook / Seb Hoyle / Lucie Holloway Citigate Dewe Rogerson Tel: 020 7638 9571 Additional details are set out below: Steve Marshall (age 50) Present directorships or partnerships: Delta PLC, Balfour Beatty PLC, SouthernWater Services Ltd Directorships or partnerships in previous five years: Queens Moat Houses PLC,Railtrack Group PLC Details of companies entering insolvency whilst a director or within 12 monthsof resignation: RT Group Holdings Ltd No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies. There is nothing further to disclose in relation to their appointment pursuantto Rule 17 of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Mar 20164:35 pmRNSPrice Monitoring Extension
11th Mar 20163:02 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20167:00 amRNS510k market clearance granted for SurgiPureT XD
9th Mar 20167:00 amRNSFurther Medicare Coverage for DermaPure®
11th Feb 20167:00 amRNSVP, Orthopaedic, Inc. North America appointed
3rd Feb 20167:00 amRNSDermaPure to be Showcased in Nine Posters at SAWC
26th Jan 201612:21 pmRNSJoint Venture Agreement
25th Jan 20167:00 amRNSHardman & Co Research Report
20th Jan 20167:00 amRNSDermaPure® breaks through $1m sales mark
19th Jan 20167:00 amRNSAppointment of Non-Executive Director
18th Jan 20167:00 amRNSOrthoPureT XM clinical trial enrolment completed
23rd Dec 201512:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Dec 20157:00 amRNSOrthoPureT XT implants successfully undertaken
5th Nov 20154:42 pmRNSIssue of equity and total voting rights
26th Oct 20157:00 amRNSIssue of equity and total voting rights
23rd Oct 20157:49 amRNSNon-Executive Director Share Purchase
14th Oct 20154:09 pmRNSEdison initiates coverage of Tissue Regenix
12th Oct 20157:00 amRNSInterim Results
4th Sep 201510:11 amRNSNotice of Interim Results and Capital Markets Day
30th Jul 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
22nd Jul 20157:00 amRNSAdditional US regional distribution agreement
26th Jun 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure®
12th Jun 201512:43 pmRNSResult of AGM
1st Jun 20159:17 amRNSDermaPure saves 18 year old's leg from frost bite
21st May 20159:51 amRNSHolding(s) in Company
20th May 20157:00 amRNSEmployee SAYE Share Plan
12th May 20157:00 amRNSDeferred Annual Bonus Award
11th May 20157:00 amRNSFinal Results
11th May 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
5th May 20157:02 amRNSUS regional distribution agreement signed
1st May 20154:01 pmRNSHolding(s) in Company
29th Apr 20157:01 amRNSDermaPure US Clinical data to be presented at SAWC
28th Apr 20157:00 amRNSOrthoPureT XT (Tendon) UK Clinical Trial Approval
9th Mar 20152:05 pmRNSNotice of Preliminary Results
6th Mar 20157:09 amRNSDermaPure gains Medicare coverage approval
5th Mar 20151:36 pmRNSIssue of equity and total voting rights
5th Mar 20151:18 pmRNSIssue of equity and total voting rights
5th Mar 201510:38 amRNSUK Patient has world's first OrthoPure XM implant
26th Feb 201510:43 amRNSResignation of Dr Alison Fielding
9th Feb 201512:05 pmRNSResult of General Meeting
4th Feb 201510:59 amRNSIssue of equity and total voting rights
22nd Jan 201511:13 amRNSResults of Placing
22nd Jan 20157:00 amRNSProposed placing of new Ordinary Shares
1st Dec 20149:45 amRNSHolding(s) in Company
28th Nov 20149:45 amRNSHolding(s) in Company
25th Nov 20148:15 amRNSNotice of allowance for US meniscus patent
5th Nov 20147:00 amRNSTissue Regenix gains Medicare and Medicaid Q code
29th Oct 20147:00 amRNSInterim Results
22nd Oct 20149:01 amRNSInterim Results and Capital Markets Day
20th Oct 201410:19 amRNSdCELL(R) presented at prestigious EACTS congress

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.